Hong Kong, China

Li-Meng Yan

This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li-Meng Yan. Retrieved from https://idiyas.com/inventor/li-meng-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Li-Meng Yan and Vaccine-Related Patent Innovation.

Introduction

Li-Meng Yan is associated with The University of Hong Kong and is named as an inventor on a patent concerning recombinant viruses and vaccine development. The supplied information identifies her location as Hong Kong, CN, and lists 1 patent.

Latest Patents

Yan’s listed patent is “Recombinant Viruses Expressing Alpha-1, 3-Galactosyltransferase and Uses Thereof.” It describes viruses containing a heterologous nucleic acid segment that encodes alpha-1,3-galactosyltransferase (α-1,3-GT). When the virus infects a host cell, the segment can express the enzyme, leading to proteins that carry α-1,3-galactose.

The patent proposes that α-1,3-galactose on proteins in infected cells may stimulate the host’s immune response to viral proteins and thereby enhance the virus’s potential as a vaccine. It also describes vaccines that include or are produced using these viruses, along with methods for making and administering the viruses and vaccines.

Career Highlights

The information provided connects Yan’s work to research at The University of Hong Kong and to an invention focused on viral vaccine design. The patent describes a strategy for modifying viral proteins to influence immune responses.

Collaborations

The supplied information names Lit Man Poon and Pui Ngan Lau as Yan’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Li-Meng Yan’s listed patent explores recombinant viruses as a platform for vaccine development by using α-1,3-GT expression to potentially strengthen immune responses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…